Moleculin Biotech Balance Sheet Health

Financial Health criteria checks 4/6

Moleculin Biotech has a total shareholder equity of $7.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $23.4M and $15.9M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$9.41m
EquityUS$7.48m
Total liabilitiesUS$15.92m
Total assetsUS$23.39m

Recent financial health updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 0K2H's short term assets ($11.6M) exceed its short term liabilities ($5.6M).

Long Term Liabilities: 0K2H's short term assets ($11.6M) exceed its long term liabilities ($10.3M).


Debt to Equity History and Analysis

Debt Level: 0K2H is debt free.

Reducing Debt: 0K2H had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 0K2H has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: 0K2H has less than a year of cash runway if free cash flow continues to reduce at historical rates of 11.9% each year


Discover healthy companies